Volume 38, Issue 23, Page 37 (1 December 2008)
44 of 63
PREVIEW
FULL TEXT
FULL-TEXT PDF (215 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
PHILADELPHIA — Despite recent hints of danger, inhaled anticholinergic drugs remain a mainstay of treatment for many patients with chronic obstructive pulmonary disease.
PII: S0300-7073(08)71448-8
doi:10.1016/S0300-7073(08)71448-8
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW